FDA-REQUIRED UPDATED REMS SAFETY INFORMATION Risk of: • Cytokine Release Syndrome (CRS), which may be life-threatening or fatal • Neurological Toxicities, which may be severe, life-threatening or fatal • Preparation and Administration Errors April 2020 The Food and Drug Administration (FDA) has required this safety notice as part of the BLINCYTO® REMS (Risk Evaluation and…
Are you a Member of NAHC?
Become a member or sign in and read full NAHC Report articles at your leisure. Membership is affordable even if you're a small business and it comes with a lot of other benefits.